Aziyo Biologics, Inc. (AZYO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.4000 |
| Open | 1.4000 |
| Bid | 1.4100 x 800 |
| Ask | 1.4900 x 900 |
| Day's Range | 1.2300 - 1.5400 |
| 52 Week Range | 1.1000 - 9.0100 |
| Volume | |
| Avg. Volume | 212,965 |
| Market Cap | 23.703M |
| Beta (5Y Monthly) | -0.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.1040 |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
- Thomson Reuters StreetEvents
Q4 2022 Aziyo Biologics Inc Earnings Call
Q4 2022 Aziyo Biologics Inc Earnings Call
- GlobeNewswire
Aziyo Biologics Reports Record Full Year 2022 Revenues
SILVER SPRING, Md., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2022. Business Highlights: Reported $49.2 million of net sales for full year 2022Fourth quarter 2022 net sales of $12.7 million, repres
- GlobeNewswire
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
SILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, and Sientra, Inc. (Nasdaq: SIEN) (“Sientra”), a medical aesthetics company uniquely focused on plastic surgery, today announced they have entered into an agreement to expand the distribution of Aziyo’s SimpliDerm product line. Under the
